close

Decipher Labs Ltd

Know More
NSEBSE
Stock not tradded

17.510.34 (1.98%)

12:00 AM,29th Sep 2023

BSE : 524752

NSE :

Sector : Health care

ISIN Code : INE643N01012

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 29 2023 | 12:00 AM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Decipher Labs Ltd

Incorporated as a private limited company in Sep.'86 Combat Drugs (CDL) was converted into a public limited company in Jun.'92. The company was promoted by Suchit Mohan Lal and Ajay Karan. CDL came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.'94. The proceeds of the issue were utilised to part-finance a Rs 3.25-cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables.CDL started commercial production in Jul.'87 on a loan-licence basis. The company acquired a full-fledged manufacturing unit located at Balanagar Hyderabad on lease from Fairchild Laboratories and commenced commercial production in Aug.'88. In Jul.'92 the manufacturing activities were shifted to the present leased premises at Kushaiguda Hyderabad. In this unit various pharmaceutical formulations such as tablets capsules and liquids are being manufactured. The product range of CDL comprises vital anti-bacterial drugs antibiotic drugs anti-inflammatory drugs haematenic drugs and protein tonic. CDL has developed in-house technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 1995-96 the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational.During 1996-97 the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product HB 2 has been well accepted in the market. The company has also filled its application for obtaining the (c)GMP and WHO GMP Certificate.During the year 1998-99 the Company initiated steps to diversify into information technology. The Company is in the process of taking over the business of M/s. Softech Institute of Information Technology & Software Development which would function as the Infotech Division of the Company. The Company also proposes to change its name to Combat Drugs and Softech Limited so as to justify both the activities of Pharmaceutical Formulations and Information Technology.

Decipher Labs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

17

EPS - TTM (₹) [S]

0.00

P/E Ratio (X) [S]

1.99

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]8.82
P/B Ratio (₹) [S]1.99
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

17.51

17.51

Week Low/High

16.20

18.00

Month Low/High

15.30

20.00

Year Low/High

12.00

37.00

All time Low/High

0.10

225.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week2.40%%-0.27-0.18%
1 Month11.39%%1.161.53%
3 Month-0.91%%2.993.51%
6 Month17.28%%14.2615.85%
1 Year-47.34%%16.7016.77%
3 Year-21.13%%73.3574.99%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
11-04-2023SURIADOSS ELUMALAI .BSEBUY6995323.48
30-09-2022BHAVISHYA ECOMMERCE PRIVATE LIMITEDBSESELL12090131.60
30-09-2022MANSI SHARE & STOCK ADVISORS PRIVATE LIMITEDBSEBUY5202431.66
30-09-2022MANSI SHARE & STOCK ADVISORS PRIVATE LIMITEDBSESELL2853831.62
30-09-2022MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBSESELL8420131.60
29-09-2022MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBSESELL12647033.40
29-09-2022MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBSEBUY21065533.25
15-09-2022BHAVISHYA ECOMMERCE PRIVATE LIMITEDBSESELL15207255.20
15-09-2022BHAVISHYA ECOMMERCE PRIVATE LIMITEDBSEBUY27169655.16
15-09-2022BP EQUITIES PVT. LTD.BSESELL8575655.13

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter16.43
Financial Institutions Banks0.00
Foreign Institutional Investors0.00
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.00
Indian Public80.66
Others Non Institutional Investors2.91
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Executive Director : Sushant Mohan Lal

Independent Director : G Venkateswara Rao

Company Sec. & Compli. Officer : Megha Agarwal

Registered Office: 4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2,Hyderabad,Telangana-500034 Ph:

Email:info@combatdrugs.in

URL:http://www.combatdrugs.in